Sonova to present at the J.P. Morgan 2025 Healthcare Conference

13.01.25 18:00 Uhr

Werte in diesem Artikel
Aktien

302,80 CHF 3,20 CHF 1,07%

Sonova Holding AG / Key word(s): Conference
Sonova to present at the J.P. Morgan 2025 Healthcare Conference

13.01.2025 / 18:00 CET/CEST

Wer­bung


Group Media & Investor Release

Staefa (Switzerland), January 13, 2025 – Sonova Holding AG (SWX: SOON), a leading provider of innovative hearing solutions, announces that its Chief Executive Officer Arnd Kaldowski will today present Sonova’s strategy and an overview of the current business dynamics at the J.P. Morgan 2025 Healthcare Conference in San Francisco, California. The presentation will take place on Monday, January 13, 2025, at 07:30pm Central European Time (CET) / 10:30am US Pacific Standard Time (PST). Presentation slides will be available at: https://www.sonova.com/en/investor-presentations.

Arnd Kaldowski, CEO of Sonova, says: “We are encouraged by the positive trends in each of our four Sonova business units and are pleased to present at the J.P. Morgan Healthcare Conference. Notably, we continue to see a strong reception for our new Phonak Infinio and Phonak Sphere Infinio platforms as well as improved sales momentum in our Audiological Care business as we have moved into the second half of our financial year. Based on these developments, we reaffirm our guidance for the fiscal year, reflecting our commitment to delivering sustained growth and value to our shareholders.”

Wer­bung

– End –

Contacts:

Investor Relations

Thomas Bernhardsgrütter   +41 58 928 33 44

Wer­bung

ir@sonova.com

 

Media Relations

Karl Hanks               +41 76 367 72 56

mediarelations@sonova.com

About Sonova
Sonova is a global leader in innovative hearing care solutions: from personal audio devices and wireless communication systems to audiological care services, hearing aids and cochlear implants. The Group was founded in 1947 and is headquartered in Stäfa, Switzerland.

Sonova operates through four businesses – Hearing Instruments, Audiological Care, Consumer Hearing and Cochlear Implants – and the core brands Phonak, Unitron, AudioNova, Sennheiser (under license) and Advanced Bionics as well as recognized regional brands. The Group’s globally diversified sales and distribution channels serve an ever growing consumer base in more than 100 countries.

In the 2023/24 financial year, the Group generated sales of CHF 3.6 billion, with a net profit of CHF 610 million. Over 18,000 employees are working on achieving Sonova’s vision of a world where everyone enjoys the delight of hearing.

For more information please visit www.sonova.com.

Disclaimer
This Media Release contains forward-looking statements, which offer no guarantee with regard to future performance. These statements are made on the basis of management’s views and assumptions regarding future events and business performance at the time the statements are made. They are subject to risks and uncertainties including, but not confined to, future global economic conditions, exchange rates, legal provisions, market conditions, activities by competitors and other factors outside Sonova’s control. Should one or more of these risks or un-certainties materialize or should underlying assumptions prove incorrect, actual outcomes may vary materially from those forecasted or expected. Each forward-looking statement speaks only as of the date of the particular statement, and Sonova undertakes no obligation to publicly update or revise any forward-looking statements, except as required by law.



End of Media Release


Language: English
Company: Sonova Holding AG
Laubisrütistrasse 28
8712 Stäfa
Switzerland
Phone: +41 58 928 33 33
E-mail: ir@sonova.com
Internet: www.sonova.com
ISIN: CH0012549785
Valor: 12549785
Listed: SIX Swiss Exchange
EQS News ID: 2066739

 
End of News EQS News Service

2066739  13.01.2025 CET/CEST

Ausgewählte Hebelprodukte auf Sonova

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Sonova

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Sonova AG

Wer­bung

Analysen zu Sonova AG

DatumRatingAnalyst
22.02.2013Sonova kaufenVontobel Research
12.02.2013Sonova kaufenVontobel Research
04.12.2012Sonova overweightMorgan Stanley
23.11.2012Sonova kaufenFuchsbriefe
14.11.2012Sonova neutralUBS AG
DatumRatingAnalyst
22.02.2013Sonova kaufenVontobel Research
12.02.2013Sonova kaufenVontobel Research
04.12.2012Sonova overweightMorgan Stanley
23.11.2012Sonova kaufenFuchsbriefe
14.11.2012Sonova overweightJ.P. Morgan Cazenove
DatumRatingAnalyst
14.11.2012Sonova neutralUBS AG
13.11.2012Sonova neutralSarasin Research
07.11.2012Sonova equal-weightMorgan Stanley
22.10.2012Sonova neutralSarasin Research
05.10.2012Sonova neutralSarasin Research
DatumRatingAnalyst
14.11.2012Sonova underperformExane-BNP Paribas SA
12.11.2012Sonova underperformExane-BNP Paribas SA
10.10.2012Sonova underperformExane-BNP Paribas SA
27.09.2012Sonova underperformExane-BNP Paribas SA

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Sonova AG nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"